Physician profile
Jacki Lea Wildeman
NPI 1184672628
$1,353.39
in general payments reported to CMS, 2019-2025
15 companies · $17.17 in 2025
The $17.17 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $748 · 2022: $389 · 2023: $199 · 2025: $17.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $216.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $312.16 | 2021-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $275.73 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $155.49 | 2021-2023 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.25 | 2021-2023 | Jardiance |
| Amgen INC. | $114.15 | 2021-2022 | |
| Pfizer INC. | $98.90 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $80.25 | 2021-2023 | Verquvo |
| Abbott Laboratories | $41.55 | 2022-2025 | Aveir |
| E.R. Squibb & Sons, L.L.C. | $38.36 | 2021-2023 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $28.01 | 2021 | |
| Cvrx, INC. | $17.49 | 2023 | Barostim Neo System |
| Irhythm Technologies, INC. | $15.87 | 2023 | Zio Xt Patch |
| Getinge USA Sales, LLC | $15.38 | 2021 | |
| Amarin Pharma, INC. | $15.12 | 2021 | |
| Cardiva Medical, INC. | $14.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacki Wildeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.